{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T01:19:29Z","timestamp":1794187169742,"version":"4.8.0"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"25","license":[{"start":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T00:00:00Z","timestamp":1750377600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,6,20]]},"abstract":"<jats:p>Uterine fibroids, also known as leiomyomas, are benign tumors of the uterus that disproportionately affect women of reproductive age, often leading to significant clinical symptoms such as abnormal bleeding, pelvic pain, and infertility. Although hormones like estrogen and progesterone have long been established as major contributors to fibroid development, recent advances have shed light on the critical role of growth factors in modulating tumor growth and fibrosis. Among these, platelet-derived growth factor (PDGF) has emerged as a key mediator of cellular proliferation, extracellular matrix deposition, and angiogenesis within fibroid tissues. PDGF exists in several isoforms (AA, BB, AB, CC, DD) and signals through PDGF receptors \u03b1 and \u03b2, activating downstream pathways such as PI3K\/AKT, RAS\/MAPK, and JAK\/STAT. These signaling events promote not only smooth muscle cell proliferation but also fibrotic remodeling by stimulating collagen and fibronectin production. PDGF also interacts with other pathways (particularly transforming growth factor-beta and sex hormones) to amplify fibroid growth and resistance to apoptosis, reinforcing a fibrotic, hormone-responsive microenvironment. Elevated expression of PDGF and its receptors in fibroids compared to normal myometrium supports its central role in pathogenesis.<\/jats:p>","DOI":"10.1097\/md.0000000000042995","type":"journal-article","created":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T17:00:48Z","timestamp":1750698048000},"page":"e42995","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["Platelet-derived growth factor (PDGF) and its impact in fibroid pathogenesis: A narrative review"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4538-0161","authenticated-orcid":false,"given":"Emmanuel Ifeanyi","family":"Obeagu","sequence":"first","affiliation":[{"name":"Department of Biomedical Laboratory Science, Africa University, Mutare, Zimbabwe."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260613","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.cytogfr.2023.10.002","article-title":"Immunosuppressive tumor microenvironment and uterine fibroids: role in collagen synthesis.","volume":"75","author":"Saad","year":"2024","journal-title":"Cytokine growth factor rev"},{"key":"R2-20260613","first-page":"38","article-title":"A review on fibroid and haptoglobin.","volume":"4","author":"Ifeanyi","year":"2018","journal-title":"Int J Curr Res Med Sci"},{"key":"R3-20260613","first-page":"R7","article-title":"Evaluation of serum haptoglobin in fibroid patients at Elele, Rivers State, Nigeria.","volume":"1","author":"Nnatuanya","year":"2017","journal-title":"Genetics"},{"key":"R4-20260613","first-page":"1","article-title":"A review on Cystatin C and fibroid.","volume":"4","author":"Ifeanyi","year":"2018","journal-title":"Int J Curr Res Med Sci"},{"key":"R5-20260613","first-page":"101","article-title":"Evaluation of serum cystatin C levels in fibroid patients in Elele.","volume":"4","author":"Nnatuanya","year":"2017","journal-title":"Arch Med"},{"key":"R6-20260613","first-page":"43","article-title":"Infertility: prevalence and consequences.","volume":"10","author":"Obeagu","year":"2023","journal-title":"Int J Curr Res Chem Pharm Sci"},{"key":"R7-20260613","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.xfss.2024.06.004","article-title":"The immune landscape of uterine fibroids as determined by mass cytometry.","volume":"5","author":"Boos","year":"2024","journal-title":"F&S Science"},{"key":"R8-20260613","doi-asserted-by":"crossref","first-page":"1330807","DOI":"10.3389\/fgene.2024.1330807","article-title":"Gene variants polymorphisms and uterine leiomyoma: an updated review.","volume":"15","author":"Upadhyay","year":"2024","journal-title":"Front Genet"},{"key":"R9-20260613","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.3390\/cells13131091","article-title":"In vivo effects of bay 11-7082 on fibroid growth and gene expression: a preclinical study.","volume":"13","author":"Chuang","year":"2024","journal-title":"Cells"},{"key":"R10-20260613","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1080\/14728222.2024.2390094","article-title":"Uterine fibroids: current research on novel drug targets and innovative therapeutic strategies.","volume":"28","author":"Ciebiera","year":"2024","journal-title":"Expert Opin Ther Targets"},{"key":"R11-20260613","doi-asserted-by":"crossref","first-page":"e3525","DOI":"10.31661\/gmj.v13i.3525","article-title":"Growth factors, signaling pathways and other biochemical markers effect on nucleotide excision repair (NER) suppression in uterine fibroids (leiomyomas): a systematic review: growth factors, signaling pathways effect on NER suppression in leiomyomas.","volume":"13","author":"Movahed","year":"2024","journal-title":"Galen Med J"},{"key":"R12-20260613","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.3390\/ijms26062458","article-title":"The molecular and cellular mechanisms of endometriosis: from basic pathophysiology to clinical implications.","volume":"26","author":"Mariadas","year":"2025","journal-title":"Int J Mol Sci"},{"key":"R13-20260613","first-page":"1","article-title":"Unveiling the role of traditional regimens in the management of uterine fibroids: a systematic review.","volume":"1","author":"Balkrishna","year":"2024","journal-title":"Health Care Women Int"},{"key":"R14-20260613","first-page":"120","article-title":"Essential growth factor receptors for fibroblast homeostasis and activation: fibroblast growth factor receptor (FGFR), platelet derived growth factor receptor (PDGFR), and transforming growth factor \u03b2 receptor (TGF\u03b2R).","volume":"13","author":"Cheng","year":"2024","journal-title":"F1000Research"},{"key":"R15-20260613","doi-asserted-by":"crossref","first-page":"e64","DOI":"10.1016\/j.fertnstert.2024.05.115","article-title":"A 3D model of uterine fibroid cellular response to compression: examining mechanotransduction in fibroid pathogenesis.","volume":"122","author":"Sax","year":"2024","journal-title":"Fertil Steril"},{"key":"R16-20260613","first-page":"236","article-title":"Hypoxia in uterine fibroids: role in pathobiology and therapeutic opportunities.","volume":"4","author":"Olson","year":"2024","journal-title":"Oxygen (Basel, Switzerland)"},{"key":"R17-20260613","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.fertnstert.2024.05.004","article-title":"Advances in uterine fibroid research: linking progesterone and the transforming growth factor-\u03b2 signaling pathway.","volume":"122","author":"Islam","year":"2024","journal-title":"Fertil Steril"},{"key":"R18-20260613","first-page":"155772","article-title":"Lipid-laden uterus: investigating uterine fibroids and lipid association.","volume":"266","author":"Sandeep","year":"2024","journal-title":"Pathol Res Pract"},{"key":"R19-20260613","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s13530-023-00198-1","article-title":"A comparative analysis of phytochemicals versus synthetic drugs\/nanomedicines in the treatment of uterine fibroid: a systematic review.","volume":"16","author":"Upadhyay","year":"2024","journal-title":"Toxicol Environmental Health Sci"},{"key":"R20-20260613","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.xfss.2024.11.003","article-title":"Sphingosine 1-phosphate acts as proliferative and fibrotic cue in leiomyoma cells.","volume":"6","author":"Rossi","year":"2025","journal-title":"F&S Sci"},{"key":"R21-20260613","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1093\/humupd\/dmt042","article-title":"The role of angiogenic factors in fibroid pathogenesis: potential implications for future therapy.","volume":"20","author":"Tal","year":"2014","journal-title":"Hum Reprod Update"},{"key":"R22-20260613","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1186\/s12967-023-04575-9","article-title":"Exploring the dynamic interplay between cancer stem cells and the tumor microenvironment: implications for novel therapeutic strategies.","volume":"21","author":"Li","year":"2023","journal-title":"J Transl Med"},{"key":"R23-20260613","first-page":"4697","article-title":"A network pharmacology approach to investigate the pharmacological effects of Guizhi Fuling Wan on uterine fibroids.","volume":"14","author":"Zeng","year":"2017","journal-title":"Exp Ther Med"},{"key":"R24-20260613","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/biolre\/ioab054","article-title":"Role of inflammation in benign gynecologic disorders: from pathogenesis to novel therapies.","volume":"105","author":"AlAshqar","year":"2021","journal-title":"Biol Reprod"},{"key":"R25-20260613","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s12094-017-1719-x","article-title":"Recommendations for biomarker testing in epithelial ovarian cancer: a National consensus statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology.","volume":"20","author":"Oaknin","year":"2018","journal-title":"Clin Transl Oncol"},{"key":"R26-20260613","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1097\/AOG.0000000000002877","article-title":"Gynecologic health and disease research at the eunicekennedyshriver national institute of child health and human development: a scientific vision.","volume":"132","author":"Tingen","year":"2018","journal-title":"Obstet Gynecol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000042995","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T13:01:34Z","timestamp":1781355694000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000042995"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,20]]},"references-count":26,"journal-issue":{"issue":"25","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000042995","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,20]]}}}